Lumenis Be. Ltd, a pioneering energy-related medical device company, has entered the healthcare market with its new edition of its breakthrough multi-application aesthetic platform, the Stellar M22™, equipped with XPL™ Technology, sponsored by four comprehensive technologies and has a green signal to treat around 30 diverse indications. The Stellar M22™ allows systematic treatment workflows and commendable patient outcomes regardless of any skin type, age and gender, covering all in one compact system.
Underlining its clinical impact the Lumenis highlighted the promising clinical data at the Annual American Society for Dermatologic Surgery (ASDS) Meeting, elaborating the platform’s remarkable potential to gain around 70% improvement in an individual independent XPL session.
The Stellar M22™ with XPL™ is a confidence and expanded inspiration for many pioneers and inventors of the IPL therapy exploratories, as it's been a valuable standard of photo rejuvenation for many decades. The Stellar M22™ with XPL™ is engineered for aesthetics professionals, all dedicated to serving the excellent modernised treatment and flaunting the best of its expertise via accelerated versatility.
The skincare market is playing in multi–billion–dollar energy-based deals, continuing with its substantial growth, while Stellar M22™ is all prepared to set a new standard bar for multi-application platforms. The platforms that stand tall on the legacy of above 30,000 installations throughout the various device generations globally.
The XPL™ (Expert Pulsed Light) Technology is the recent advancement of Lumenis in pulsed light technology involving sub-pulsing technology, Advanced Pulse Design and 8 expert filters. Each is built for precision control and the vast versatility of every variable of the pulse parameters. The XPL™ Glide Mode is a NEW feature allowing the fastest and accurate treatments in motion with leveraged speed passes and comfort, which is suited for coverage of huge treatment areas and skin rejuvenation treatments.
The technology promoted diverse treatment modalities that identify texture improvement and uneven skin tone, dark tattoo removal, and large vascular lesions. The ResurFX® BrushFX™ Mode is a NEW potential serving a natural touch texture effects with optimised air-brush style mixed for ease, aesthetics finishes. The Hybrid treatment modalities encompass a unique treatment like PhotoFABULOUS™. This treatment merges two popular Stellar technologies, ResurFX and XPL, for full-fledged skin rejuvenation and SmoothGlo™, coupled with Lumenis’s player systems.
Holding M.Pharm in Pharmaceutical Chemistry, Chandni crafts cutting-edge, research-driven healthcare news for Towards Healthcare, combining scientific depth with innovative storytelling to simplify complex topics for global readers.
